News and Trends 21 Mar 2023
Karuna Therapeutics sees positive schizophrenia trial results
Karuna Therapeutics, Inc. has announced positive topline results from its phase 3 EMERGENT-3 trial evaluating the efficacy, safety, and tolerability…
News and Trends
- Latest Posts
News and Trends 21 Mar 2023
Campbell Neurosciences creates saliva-based test for suicidal thoughts
Therapeutic Solutions International (TSOI) has announced that its spin-off biotech company, Campbell Neurosciences, Inc., obtained successful validation of its suicidal…
News and Trends 20 Mar 2023
SpyBiotech receives more than $4 million to develop vaccine platform
UK-based SpyBiotech has received a grant of more than $4 million from the Bill & Melinda Gates Foundation to build…
News and Trends 17 Mar 2023
67% five-year survival rate in glioblastoma therapy, according to CANbridge Pharmaceuticals study
CANbridge Pharmaceuticals Inc. has announced that its therapy for glioblastoma has shown a 67% survival rate at five years, three…
ADVERTISEMENT
News and Trends 17 Mar 2023
Likang gets trial ok for China’s first personalized cancer vaccine
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted vaccine for advanced solid tumors,…
News and Trends 17 Mar 2023
Purple Biotech sees positive results from cancer study
Purple Biotech Ltd. has released new results from exploratory analyses conducted as part of a phase 1 dose escalation study…
News and Trends 17 Mar 2023
Beyond Biotech podcast 38: Hello Tomorrow Global Summit
The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we feature interviews with four of…
News and Trends 17 Mar 2023
How cancer cells repair DNA damage from radiotherapy
A team of scientists led by Kei-ichi Takata from the Center for Genomic Integrity (CGI) within the Institute for Basic…
News and Trends 16 Mar 2023
Inspire Biotherapeutics launches to target lung diseases through gene therapy
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies for monogenic and acquired diseases…
News and Trends 16 Mar 2023
Mediar Therapeutics boosts fibrosis portfolio with $105M financing
Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and even reverse the course of…
ADVERTISEMENT
News and Trends 15 Mar 2023
Nanite receives funding to deliver genetic therapies to the lungs
Nanite Inc. has announced an investment from the Cystic Fibrosis Foundation of up to $2 million to develop gene delivery…
News and Trends 15 Mar 2023
Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, has launched its new pipeline…
News and Trends 14 Mar 2023
Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline
Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share for a total enterprise value…
News and Trends 14 Mar 2023
Astellas menopause study meets endpoints but leukemia drug disappoints
There was good and bad news this week from Japanese company Astellas Pharma Inc. as one of its trials yielded…
News and Trends 14 Mar 2023
How the microbiome can predict cancer immunotherapy success
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable treatment outcomes. An international team…
News and Trends 14 Mar 2023
Calliditas shares rise as phase 3 endpoints met in kidney disease trial
Swedish company Calliditas Therapeutics AB has announced positive topline results from the global, randomized, double-blind, placebo-controlled phase 3 clinical trial…
ADVERTISEMENT
News and Trends 13 Mar 2023
New therapy for prevention and treatment of COVID-19
ExeVir Bio, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences institute, have published a pre-print paper by…
News and Trends 13 Mar 2023
Sanofi adds diabetes drug through Provention Bio $2.9B acquisition
Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type…
News and Trends 9 Mar 2023
Twisted blood vessels reveal cancer treatment success potential
Picture Health has announced plans to commercialize a new artificial intelligence (AI)-powered biomarker with the potential to transform the way…
News and Trends 9 Mar 2023
Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a €15.5 million ($16.4 million) Series A…
